Search

Displaying results 9891 - 9900 of 10000 in total
  1. Drug

    KAND567

    go.drugbank.com/drugs/DB16511
    Investigational

    Because COVID-19 involves cytotoxic cells associated with this pathway, KAND567 is currently being tested as a treatment for those with the illness[L32908].

  2. Drug

    Cilofungin

    go.drugbank.com/drugs/DB20369
    Experimental

    Cilofungin is a small molecule drug. The usage of the INN stem '-fungin' in the name indicates that Cilofungin is a antifungal antibiotic. Cilofungin has a monoisotopic molecular weight of 1029.49 Da.

    Categories: Amino Acids, Peptides, and Proteins
  3. Drug

    Talaporfin

    go.drugbank.com/drugs/DB11812
    Investigational

    Talaporfin has been investigated for the treatment of Port-Wine Stain and Benign Prostatic Hyperplasia.

  4. Drug

    Rufloxacin

    go.drugbank.com/drugs/DB13772
    Investigational

    Rufloxacin is a quinolone antibiotic.[A31894]

    Categories: Topoisomerase II Inhibitors
  5. Drug

    norUrsodeoxycholic acid

    go.drugbank.com/drugs/DB16260
    Investigational

    norUrsodeoxycholic acid is under investigation in clinical trial NCT03872921 (Norursodeoxycholic Acid vs Placebo in PSC).

    Categories: Bile Acids and Salts
  6. Drug

    IMCY-0141

    go.drugbank.com/drugs/DB17019
    Investigational

    IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin

  7. Drug

    GLB-001

    go.drugbank.com/drugs/DB32795
    Investigational

    GLB-001 is a orally bioavailable molecular glue degrader targeting casein kinase 1 alpha (CK1a).[L56124, L56125, L56126]

  8. Drug

    Dociparstat sodium

    go.drugbank.com/drugs/DB16481
    Investigational

    Categories: Heparin and similars
  9. Drug

    Prasterone enantate

    go.drugbank.com/drugs/DB16625
    Approved

    Categories: Hormones, Hormone Substitutes, and Hormone Antagonists
  10. Drug

    Pamiparib

    go.drugbank.com/drugs/DB14769
    Investigational

    Pamiparib is under investigation in clinical trial NCT03933761 (Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression … on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy).

    Categories: Antineoplastic and Immunomodulating Agents